Lv5
860 积分 2021-08-19 加入
Risk of Exacerbation and Pneumonia with Single-Inhaler Triple versus Dual Therapy in IMPACT
1个月前
已关闭
Effects of YuPingFeng granules on acute exacerbations of COPD: a randomized, placebo-controlled study
1个月前
已完结
Effect of traditional Chinese medicine combined with conventional Western medicine for patients with severe/very severe chronic obstructive pulmonary disease: a multi-center, randomized, double-blind, controlled study
1个月前
已完结
Bu-Fei Yi-Shen Granules Reduce Acute Exacerbations in Patients with GOLD 3-4 COPD: A Randomized Controlled Trial
1个月前
已完结
Exploring the mechanism of guben kechuan granules in the treatment of COPD via network pharmacology, molecular docking and molecular dynamics simulations
1个月前
已完结
Integrated Systems Pharmacology and Surface Plasmon Resonance Approaches to Reveal the Synergistic Effect of Multiple Components of Gu-Ben-Ke-Chuan Decoction on Chronic Bronchitis
1个月前
已完结
Clinical research policy for oral mucositis associated with cancer treatment (J-SUPPORT)
2个月前
已关闭
Dapagliflozin in Patients with Chronic Kidney Disease
2个月前
已完结
Efficacy and Safety of Niaoduqing Particles for Delaying Moderate-to-severe Renal Dysfunction: A Randomized, Double-blind, Placebo-controlled, Multicenter Clinical Study
2个月前
已完结
Rifasutenizol-based triple therapy versus bismuth plus clarithromycin-based triple therapy for first-line treatment of Helicobacter pylori infection in China (EVEREST-HP): a phase 3, multicentre, randomised, triple-dummy, double-blind, controlled, non-inferiority trial
2个月前
已完结
皖公网安备34019202002308
